Abstract
The study is aimed at evaluating the effectiveness and safety of the moxibustion procedure in the treatment of pain and improving the functionality of the lower extremities in patients with diabetes mellitus and peripheral neuropathy. Materials and methods. The study was conducted at the Republican Clinical Hospital in Makhachkala from January to May 2024. The study involved 20 patients aged 18 to 75 years suffering from diabetes and peripheral neuropathy. The participants were randomly assigned to two groups: the moxibustion group and the control group in a ratio of 1:1. For 8 weeks, patients in the intervention group underwent moxibustion sessions three times a week, followed by a 4-week follow-up period. The assessment was performed using algometry, LANSS, VAS, NPS, and FAAM scales, as well as a 6-minute walking test. Laboratory tests included the measurement of serum HbA1c and albumin levels. Results. The moxibustion procedure resulted in a significant reduction in pain and improved physical function in the moxibustion group compared to the control group. Changes in pain scores (algometry, LANSS, VAS, and NPS) and in the 6-minute walking test were statistically significant (p<0.05). At the same time, there were no significant changes in HbA1c and albumin levels. The side effects were minimal and did not require medical intervention. Conclusions. The results of the study showed that moxibustion is an effective and safe method of treating pain and improving functional capabilities in patients with diabetic neuropathy. Despite the positive results, more extensive and lengthy studies are needed to confirm the long-term effectiveness and safety of this procedure.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call